title: ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
abstract: The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines makes every effort to avoid any actual, potential, or perceived conflict of interest that might arise as a result of an industry relationship or personal interest of the writing committee. Specifically, all members of the writing committee, as well as peer reviewers of the document, were asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing committee at each meeting, and updated and reviewed by the writing committee as changes occur. Please see Appendix 1 for author relationships with industry and Appendix 2 for peer reviewer relationships with industry. These guidelines attempt to define practices that meet the needs of most patients in most circumstances. These guideline recommendations reflect a consensus of expert opinion after a thorough review of the available, current scientific evidence and are intended to improve patient care. If these guidelines are used as the basis for regulatory/payer decisions, the ultimate goal is quality of care and serving the patient's best interests. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and patient in light of all the circumstances presented by that patient.
authors.forename: Lee A
authors.initials: LA
authors.lastname: Fleisher
authors.forename: Joshua A
authors.initials: JA
authors.lastname: Beckman
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Brown
authors.forename: Hugh
authors.initials: H
authors.lastname: Calkins
authors.forename: Elliott L
authors.initials: EL
authors.lastname: Chaikof
authors.forename: Kirsten E
authors.initials: KE
authors.lastname: Fleischmann
authors.forename: William K
authors.initials: WK
authors.lastname: Freeman
authors.forename: James B
authors.initials: JB
authors.lastname: Froehlich
authors.forename: Edward K
authors.initials: EK
authors.lastname: Kasper
authors.forename: Judy R
authors.initials: JR
authors.lastname: Kersten
authors.forename: Barbara
authors.initials: B
authors.lastname: Riegel
authors.forename: John F
authors.initials: JF
authors.lastname: Robb
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000572:American Heart Association; D002309:Cardiology; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D007431:Intraoperative Complications / Q000517:prevention & control*; D019990:Perioperative Care; D014481:United States
chemical_list: D000319:Adrenergic beta-Antagonists